Rizzo et al analyzed a cohort of 26 LCTs (18 clinically malignant or histologically aggressive) using next‐generation sequencing and immunohistochemistry, finding enrichment for FH alterations among malignant/aggressive neoplasms [14]. The gene discussed is FH; the disease is neoplasm.